Thomas de Vlaam
InvestorPartner at Pillar VC · Board director at Amplifyer Bio
Boston, Massachusetts, United States
About
Thomas de Vlaam has built his career in biotech. Before Pillar VC, he was part of the founding team of Quotient Therapeutics at Flagship Pioneering, and earlier founded and led Amylon Therapeutics, an RNA therapeutics startup for rare neurodegenerative disease that he spun out of ProQR Therapeutics, where he headed CNS innovation. He holds a B.Sc. in International Medicine and Global Health and has contributed to multiple patents and publications.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Amplifyer Bio
Intro paths
→
In turn, Thomas can intro founders to Amplifyer Bio's investors below.
Amplifyer Bio's investors · 1
Experience
- Pillar VCPartnercurrent2024 — present
- Pillar VCPrincipal2022 — 2024
- Flagship PioneeringCo-Founder FL86 (Quotient Therapeutics)2021 — 2022
- Flagship PioneeringAssociate2021 — 2022Cambridge, Massachusetts, United States
- Amylon TherapeuticsFounder & CEO2017 — 2022Leiden, the Netherlands
- ProQR Therapeutics NVInnovation lead CNS2015 — 2017Leiden
- ProQR Therapeutics NVResearch Intern2014 — 2015Leiden
- University Medical Center GroningenResearch Intern2014
- Summer School of Transplantation Medicine (SSTx')Student committee2012 — 2014
Investments
Investor
Amplifyer BioArvada TherapeuticsThymmune
Per the firm's website.
Colleagues at Pillar VC
Alec Nielsen
Founder & CEO, Asimov & Venture Partner at Pillar VC
Alex Reinhart
Associate at Pillar VC
Alex Ting
Director of Events & Operations at Pillar VC
Andras Forgacs
Co-Founder & Board Director, Modern Meadow, Fork & Goode, Organovo & Founding Pillar at Pillar VC
Andrea Coravos
Co-founder/CEO, HumanFirst & Venture Partner at Pillar VC
Andy Beck
CEO, PathAI & Founding Pillar at Pillar VC
Ash Ashutosh
CEO, Actifio & Founding Pillar at Pillar VC
Ash Ashutosh
Executive Advisory Board at NYU Innovation Venture Fund
Frequently asked questions
- Who is Thomas de Vlaam?
- Thomas de Vlaam has built his career in biotech. Before Pillar VC, he was part of the founding team of Quotient Therapeutics at Flagship Pioneering, and earlier founded and led Amylon Therapeutics, an RNA therapeutics startup for rare neurodegenerative disease that he spun out of ProQR Therapeutics, where he headed CNS innovation. He holds a B.Sc. in International Medicine and Global Health and has contributed to multiple patents and publications.
- Where does Thomas de Vlaam work?
- Thomas de Vlaam is Partner at Pillar VC and Board director at Amplifyer Bio.
- What does Thomas de Vlaam invest in?
- Thomas de Vlaam invests in Biotech.
- What companies has Thomas de Vlaam invested in?
- Investments tracked here include Amplifyer Bio, Arvada Therapeutics, Thymmune.
- Where did Thomas de Vlaam go to school?
- Thomas de Vlaam studied at University of Groningen (Bachelor’s Degree, Medicine).
Same school
Also attended University of Groningen137
Ragnar JongenInvestor at DN CapitalGizem CakilInvestor at OpenView Venture PartnersYtsen van der MeerPrincipal at Cottonwood Technology FundJelle Van de PutteFund Administrator at Capricorn Venture PartnersLaura LentzExecutive Assistant at Castle Island VenturesChristophe de MontillePartner at Beyond Capital Ventures
+ 131 more
Shared employers
Also worked at Pillar VC31
Ellen RubinPartner at Glasswing VenturesChris FaheySVP, Talent & Human Resources at Volition CapitalJamie GoldsteinFounding/Managing Partner at Pillar VCSarah HodgesGeneral Partner at Pillar VCTony KulesaPartner at Pillar VCParker McKeePartner at Pillar VC
+ 25 more
Also worked at Flagship Pioneering76
Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringSamir KaulInvestor at Khosla VenturesCassidy BlundellPartner at Mission BiocapitalDavid KoleskyPrincipal at MPM BioImpactDiana BernsteinDirector at Northpond Ventures
+ 70 more
